HomeCompareEFRTF vs CL

EFRTF vs CL: Dividend Comparison 2026

EFRTF yields 8.76% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EFRTF wins by $80.4K in total portfolio value
10 years
EFRTF
EFRTF
● Live price
8.76%
Share price
$5.27
Annual div
$0.46
5Y div CAGR
22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$121.2K
Annual income
$31,242.90
Full EFRTF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — EFRTF vs CL

📍 EFRTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEFRTFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EFRTF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EFRTF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EFRTF
Annual income on $10K today (after 15% tax)
$744.95/yr
After 10yr DRIP, annual income (after tax)
$26,556.47/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, EFRTF beats the other by $21,964.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EFRTF + CL for your $10,000?

EFRTF: 50%CL: 50%
100% CL50/50100% EFRTF
Portfolio after 10yr
$81.0K
Annual income
$18,322.43/yr
Blended yield
22.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

EFRTF
Analyst Ratings
5
Buy
3
Hold
Consensus: Buy
Altman Z
0.6
Piotroski
5/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EFRTF buys
0
CL buys
0
No recent congressional trades found for EFRTF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEFRTFCL
Forward yield8.76%2.43%
Annual dividend / share$0.46$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR22.8%28.6%
Portfolio after 10y$121.2K$40.8K
Annual income after 10y$31,242.90$5,401.96
Total dividends collected$88.6K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: EFRTF vs CL ($10,000, DRIP)

YearEFRTF PortfolioEFRTF Income/yrCL PortfolioCL Income/yrGap
1← crossover$11,776$1,076.24$11,012$312.01+$764.00EFRTF
2$14,055$1,454.55$12,196$412.95+$1.9KEFRTF
3$17,031$1,992.38$13,599$549.66+$3.4KEFRTF
4$20,994$2,770.77$15,288$736.64+$5.7KEFRTF
5$26,384$3,919.83$17,353$995.28+$9.0KEFRTF
6$33,884$5,653.50$19,926$1,357.80+$14.0KEFRTF
7$44,589$8,332.81$23,194$1,873.82+$21.4KEFRTF
8$60,295$12,584.49$27,439$2,621.52+$32.9KEFRTF
9$84,045$19,529.99$33,088$3,727.38+$51.0KEFRTF
10$121,171$31,242.90$40,806$5,401.96+$80.4KEFRTF

EFRTF vs CL: Complete Analysis 2026

EFRTFStock

Nexus is a growth oriented real estate investment trust focused on increasing unitholder value through the acquisition, ownership and management of industrial, office and retail properties located in primary and secondary markets in North America. The REIT currently owns a portfolio of 73 properties comprising approximately 4.1 million square feet of rentable area. The REIT has approximately 109,910,000 units issued and outstanding. Additionally, there are Class B LP Units of subsidiary limited partnerships of Nexus REIT issued and outstanding, which are convertible into approximately 25,667,000 REIT Units.

Full EFRTF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this EFRTF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EFRTF vs SCHDEFRTF vs JEPIEFRTF vs OEFRTF vs KOEFRTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.